Please use this identifier to cite or link to this item: https://doi.org/10.1158/0008-5472.CAN-04-1207
DC FieldValue
dc.titleThe Ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer
dc.contributor.authorLo, T.L.
dc.contributor.authorYusoff, P.
dc.contributor.authorFong, C.W.
dc.contributor.authorMcCaw, B.J.
dc.contributor.authorWong, E.S.M.
dc.contributor.authorLeong, H.F.
dc.contributor.authorGuy, G.R.
dc.contributor.authorGuo, K.
dc.contributor.authorZeng, Q.
dc.contributor.authorPutti, T.C.
dc.contributor.authorYang, H.
dc.contributor.authorPhillips, W.A.
dc.date.accessioned2012-02-01T05:23:38Z
dc.date.available2012-02-01T05:23:38Z
dc.date.issued2004
dc.identifier.citationLo, T.L., Yusoff, P., Fong, C.W., McCaw, B.J., Wong, E.S.M., Leong, H.F., Guy, G.R., Guo, K., Zeng, Q., Putti, T.C., Yang, H., Phillips, W.A. (2004). The Ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Research 64 (17) : 6127-6136. ScholarBank@NUS Repository. https://doi.org/10.1158/0008-5472.CAN-04-1207
dc.identifier.issn00085472
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/30345
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1158/0008-5472.CAN-04-1207
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentPATHOLOGY
dc.description.doi10.1158/0008-5472.CAN-04-1207
dc.description.sourcetitleCancer Research
dc.description.volume64
dc.description.issue17
dc.description.page6127-6136
dc.description.codenCNREA
dc.identifier.isiut000223603200031
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

145
checked on Jun 21, 2022

WEB OF SCIENCETM
Citations

142
checked on Jun 21, 2022

Page view(s)

248
checked on Jun 23, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.